Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice – Lessons for tumor immunity
2008

Studying Tumor Immunity in Chimeric Mice

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wagner Alexander Y, Holle Eric, Holle Lori, Yu Xianzhong, Schwamberger Günter

Primary Institution: The Oncology Research Institute, Greenville Hospital System University Medical Center

Hypothesis

How do local and systemic tumor immunity and tolerance interact in the rejection of B16 melanoma cells in chimeric mice?

Conclusion

The study suggests that local immune tolerance mechanisms significantly influence the growth and rejection of tumors in chimeric mice.

Supporting Evidence

  • B16 tumors grew faster in mice with full chimerism compared to syngeneic hosts.
  • Chimeric mice lacking C57-derived skin showed reduced or absent tumor growth.
  • Immune cell analysis did not show significant differences between chimeric mice and their donor strains.

Takeaway

Researchers created special mice to see how their immune systems react to tumors, finding that the skin's immune environment plays a big role in whether tumors grow or are rejected.

Methodology

The study involved creating chimeric mice from two different mouse strains and analyzing tumor growth and immune cell frequencies.

Potential Biases

Potential bias in interpreting results due to the unique genetic background of the chimeric mice.

Limitations

The study primarily focuses on a specific mouse model and may not fully represent human tumor immunity.

Participant Demographics

Chimeric mice derived from C57/BL6 and FVB strains.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-8-370

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication